Much like breast tumors.

Aromatase inhibitors might slow development of lung cancer A couple of years ago researchers found that, much like breast tumors, some lung tumors also thrive on estrogen. Now a medical student conducting study on a Howard Hughes Medical Institute fellowship and colleagues have managed to stop the growth of human lung tumor cells in mice with a course of breast cancer medicines called aromatase inhibitors . The studies are reported in the December 15, 2005 problem of the journal Malignancy Research. It was an all natural progression of the task that had already been carried out linking estrogen and lung malignancy, stated Olga Weinberg, who delayed her fourth yr at Vanderbilt University College of Medicine to work on the task.

.. Array BioPharma to provide positive interim outcomes of Phase 1 ARRY-380 trial at ASCO Symposium Array BioPharma Inc. today announced positive interim results of its novel, oral HER2 inhibitor, ARRY-380, in a Stage 1 trial in individuals with advanced cancer. These email address details are being shown at the 2010 ASCO Breast Tumor Symposium in National Harbor, Maryland. Twenty-nine % of the patients had a partial response or steady disease for half a year or much longer. Thirteen of the 17 sufferers got measurable disease as defined by the Response Evaluation Requirements in Solid Tumors ; of the patients, seven got regressions in target lesions.